Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 4
CSP #2015 - Multicenter, Randomized, Double-blind Comparator Study of Antipsychotics Pimavanserin and Quetiapine for Parkinson''s Disease Psychosis (C-SAPP)
Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking prob…
Parkinson's Disease Psychosis
Estimated
~$10 – $5,625
VA Office of Research and DevelopmentNCT04373317
Phase 4
A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease
The primary objective of this study is to determine whether treatment with pimavanserin or quetiapine is associated with a greater improvement in psychosis whe…
Parkinson's Disease PsychosisDementia With Lewy Bodies
Estimated
~$10 – $6,250
The University of Texas Health Science Center at San AntonioNCT05590637